Precision Biosciences Inc (DTIL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 122,231 | 137,794 | 158,132 | 189,576 | 212,051 |
| Receivables | 3,510 | 652 | 694 | 720 | 715 |
| Other current assets | 12,036 | 503 | 1,767 | 2,784 | 307 |
| TOTAL | $145,852 | $147,864 | $169,017 | $199,105 | $225,365 |
| Non-Current Assets | |||||
| PPE Net | 8,739 | 18,249 | 18,591 | 11,815 | 21,791 |
| Investments And Advances | 1,807 | 1,807 | 2,638 | 4,748 | 3,091 |
| Intangibles | 977 | 1,552 | 1,525 | 731 | 1,969 |
| Other Non-Current Assets | 6,969 | 12,225 | 12,731 | 21,770 | 19,517 |
| TOTAL | $18,492 | $33,833 | $35,485 | $39,064 | $46,368 |
| Total Assets | $164,344 | $181,697 | $204,502 | $238,169 | $271,733 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 22,896 | 781 | 701 | 653 | 1,061 |
| Accrued Expenses | 5,296 | 5,780 | 4,384 | 6,931 | 8,473 |
| Other current liabilities | 1,845 | 1,211 | 1,412 | 745 | 1,228 |
| TOTAL | $50,617 | $56,399 | $46,859 | $59,664 | $61,148 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 22,270 | 22,223 | 22,173 |
| Deferred Revenues | 17,445 | 23,811 | 38,268 | 46,192 | 48,405 |
| Other Non-Current Liabilities | 10,766 | 13,173 | 12,432 | 12,977 | 13,522 |
| TOTAL | $84,664 | $91,257 | $117,466 | $118,072 | $126,205 |
| Total Liabilities | $135,281 | $147,656 | $164,325 | $177,736 | $187,353 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 3,961 | 3,832 | 3,789 | 3,706 | 3,695 |
| Common Shares | 1 | 1 | 1 | 1 | 1 |
| Retained earnings | -473,342 | -465,263 | -453,372 | -428,312 | -399,824 |
| Other shareholders' equity | 48 | 48 | 48 | 48 | 48 |
| TOTAL | $29,063 | $34,041 | $40,177 | $60,433 | $84,380 |
| Total Liabilities And Equity | $164,344 | $181,697 | $204,502 | $238,169 | $271,733 |